Download the TCR-based Therapies Summit Agenda
CAR T therapies have shown life-saving success in hematological indications, but are yet to show good efficacy in solid tumors.
A new wave of cell immunotherapy may be set to dominate solid tumor indications as TCR-based therapies are charged to invade the hostile microenvironment and tackle tumor indications.
This is your opportunity to gain the know-how across cell immunotherapy with in-depth discussion and insights from pioneers of this exciting new field.
Gain exclusive insights and network with industry leaders at the only TCR-Based Therapies Summit designed to optimize your TCR approach, enhance target selection & accelerate your therapy into the clinic, bringing life-saving therapy to patients who need it the most.
Download the Event Guide to discover:
- Never-before seen data from novel companies
- Collaboration with experts in 2 deep-dive workshop sessions on TCR preclinical development & Manufacturing and Logistics
- 2 open panel discussions with industry leaders
And much more… Get your copy of the full event guide below!